. Thorax, 31, [87] [88] [89] [90] . Phytohaemagglutinin and transfer factor in the leucocyte migration inhibition test in patients with sarcoidosis. A new system of phytohaemagglutinin stimulation in vitro using the leucocyte migration inhibition test has been applied to patients with active and inactive sarcoidosis and subjects with a persistently negative response to tuberculin. Patients with active sarcoidosis and the tuberculin-negative subjects have a depressed response to the mitogen. This response is improved by the addition of transfer factor to the cultures.
Phytohaemagglutinin (PHA) stimulation in the lymphocyte transformation test has been used for several years as a non-specific measure of cellmediated immune function. Recently, an alternative method for measuring response to PHA has been described using the leucocyte migration inhibition test system (Morison, 1974) .
The present study was undertaken to explore some of the possibilities of this test in the investigation of patients with active and inactive sarcoidosis and subjects with a persistently negative response to tuberculin. In addition, the influence of transfer factor on the results was examined.
MATERIALS AND METHODS

PATIENTS Three groups were investigated:
10 patients with active sarcoidosis. The diagnosis had been established on clinical, histological, and radiological grounds. There were five men and five women, mean age 40 with a range of25-56 years. Two of the patients had received prednisone, 5 mg daily, over the preceding three and six months.
5 patients with inactive sarcoidosis. These patients had all had bilateral hilar lymphadenopathy, a negative Mantoux test, and a positive histological diagnosis established. TRANSFER FACTOR A quantity of transfer factor was prepared from a normally responsive subject according to the method of Lawrence (Lawrence and AlAskari, 1971 ). In summary, the method is: the leucocytes are separated from 500 ml venous blood, frozen, and thawed 10 times, treated with pancreatic deoxyribonuclease, and then dialysed across a cellophane membrane against normal saline at 4°C for 24 hours. The dialysateisthenfilteredthrougha millipore filter before use. The amount of transfer factor added to each culture chamber in the present study was the amount extracted from the leucocytes contained in 10 ml of donor blood.
RESULTS
The results of PHA stimulation are shown in thc Figure. It can be seen that the mean migration index in patients with active sarcoidosis is abnormal (0 54). Six of the 10 patients had a result above 0 50 and all were above 0 30. In contrast, all patients with inactive sarcoidosis had a result below 0 30, and the mean index of 0-19 is similar to the mean index of 0-15 in the controls. The tuberculin negative group had a mean index similar to that found in the active sarcoid group and all had an index above 030.
The results obtained on the addition of transfer factor to the cultures are shown in the (Morison, 1974) , a modification of the leucocyte migration limitation test, using PHA stimulation, has been described. The result for this test can be available within 24 hours, equipment is minimal, and several patients can be examined at the same time. The test can be done in a routine laboratory and therefore permits the evaluation of cellular immune function in a greater number of patients with conditions such as sarcoidosis. The present study indicates that response to PHA in this test system is relatively depressed in patients with active sarcoidosis. Using the lymphocyte transformation test, the response to PHA has been variously reported as normal (Girard, Poupon, and Press, 1971; Horsmanheimo, 1972) and abnormal (Hirschhorn et al., 1964; Buckley, Nagaya, and Sieker, 1966) . Recently, it has been suggested (Mangi et al., 1974a) that steroids used for treatment may explain these contradictory results and be at least partly responsible for an abnormal result. However, this does not explain the findings in the present study as none of the results in patients with active sarcoidosis was normal and only two ofthe patients were on a low dose of steroids. .
. .
Phytohaemagglutinin and transfer factor in the leucocyte migration inhibition test
The response to PHA in patients with inactive sarcoidosis was within normal limits in all cases. This agrees with an in vivo study of cellular immunity using tuberculin reactivity (Selvoos and Niemisto, 1972) in which it was found that although immunity may be depressed during the active phase of sarcoidosis, it returns to normal in most cases with resolution of the disease. In contrast, an in vitro study including PHA stimulation found some impairment of immune function remained after clinical and radiological resolution of sarcoidosis (Osada et al., 1972) . A large prospective study on patients known to be tuberculin positive before the sarcoidosis, correlating in vivo and in vitro tests, is required to resolve these conflicting results.
The precise nature of transfer factor is unknown but it is established that dialysable extracts of leucocytes can transfer cellular immunity and activate such immunity when it is depressed. Transfer factor has been shown to have an effect on the depression of cellular immunity in sarcoidosis. An in vivo study (Lawrence and Zweiman, 1968) demonstrated that sensitivity to tuberculin could be transferred locally to the site of injection of transfer factor but systemic spread of this sensitivity in patients with sarcoidosis was very weak. In addition, it has been shown (Valentine and Lawrence, 1969 ) that transfer factor can, under in vitro conditions, increase the sensitivity of lymphocytes to an added antigen. The present work suggests that this also applies to a mitogen since six of the seven patients with sarcoidosis and two of the tuberculin negative subjects showed an increased sensitivity to PHA in the presence of transfer factor.
The question arises: does this finding lead to a better understanding of the mechanism of the defect in cellular immunity in sarcoidosis? Recent findings suggest that a serum inhibitor is responsible, at least in part, for the defect (Belcher, Carney, and Nankervis, 1974; Mangi et al., 1974b 
